Finance

Beta
Lists
4597:TYO
Solasia Pharma KK
¥24.00
-4.00%
(-1.00) 1D
Jun 2, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4597...
Open
¥26
High
¥26
Low
¥24
Mkt. cap
6.56B
Avg. vol.
68.58M
Volume
72.47M
52-wk high
¥48
52-wk low
¥24
EPS
-¥4
Shares outstanding
104.68M
No. of employees
22
Open
¥26
High
¥26
Low
¥24
Mkt. cap
6.56B
Avg. vol.
68.58M
Volume
72.47M
52-wk high
¥48
52-wk low
¥24
EPS
-¥4
Shares outstanding
104.68M
No. of employees
22
News stories
From sources across the web
About Solasia Pharma KK
CEOYoshihiro Arai
Employees22
Founded2006
Headquarters-
SectorBiotechnology
Websitesolasia.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
24.00M
42.00M
338.00M
6.00M
Cost of goods sold
10.00M
1.00M
191.00M
1.00M
Cost of revenue
10.00M
1.00M
191.00M
1.00M
Research and development expenses
121.00M
82.00M
116.00M
112.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134.00M
134.00M
178.00M
198.00M
Operating expense
255.00M
216.00M
294.00M
310.00M
Total operating expenses
265.00M
217.00M
485.00M
311.00M
Operating income
-241.00M
-175.00M
-147.00M
-305.00M
Other non operating income
-
-3.00M
-1.00M
-
EBT including unusual items
-263.00M
-171.00M
-150.00M
-307.00M
EBT excluding unusual items
-263.00M
-171.00M
-150.00M
-307.00M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-263.00M
-171.00M
-150.00M
-307.00M
Net profit margin
-1,095.83%
-407.14%
-44.38%
-5,116.67%
Earnings per share
-
-
-
-
Interest and investment income
-
7.00M
-
1.00M
Interest expense
-20.00M
-
-1.00M
-4.00M
Net interest expenses
-20.00M
7.00M
-1.00M
-3.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-232.00M
-165.00M
-138.00M
-296.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer